Discussion about this post

User's avatar
The AI Architect's avatar

The Lilly NVIDIA supercomputer is a massve capital deployment signal that pharma is done waiting 15 years for clinical trial readouts when you can simulate millions of molecular interactions in silico first. The irony is that they named it TuneLab when they could have leaned into the SkyNet joke harder, but I suppose regulatory optics matter when you're trying to convince the FDA that your AI designed molecules are safe for humans. The Peak Data problem you highlighted with wearables bombarding consumers is exactly why healthtech needs an orchestration layer that prioritizes signal versus noise rather than just collecting more biometric streams. That NHS one day prostate cancer diagnostic service in Leeds shows how AI acceleration can collapse patient pathways without requiring massive behavior change from clinicians, which is usually the sticking point in adoption.

2 more comments...

No posts

Ready for more?